Annexin announces allowance of a new U.S. Patent covering manufacturing of ANXV

Annexin Pharmaceuticals AB (publ) announces that the U.S. Patent and Trademark Office has allowed an issue of the new patent, further strengthening the intellectual property and key coverage for the Annexin ‘s therapeutic product candidate ANXV.

The release as fetched from its publisher. annexinpharma.com ↗